Mangalam Drugs And Organics Ltd.

Financial

	Mangalam Drugs&Org.	Bal Pharma	Tyche Inds
Operational Metrics
Unclassified
Advertisement Spend as a % of Total Sales	0.5 %	n/a	0.03 %
R&D as a % of Total Sales	3.31 %	1.06 %	1.28 %
Financials
5 yr Average ROE	7.15 %	8.41 %	14.86 %
5yr average Equity Multiplier	2.25	4.51	1.18
5yr Average Asset Turnover Ratio	1.24	1.01	0.6
5yr Avg Net Profit Margin	2.38 %	1.86 %	20.15 %
Price to Book	0.81	1.73	1.08
P/E	0.0	18.7	12.13
5yr Avg Cash Conversion Cycle	51.34 Days	27.6 Days	86.71 Days
Inventory Days	94.22 Days	99.82 Days	61.45 Days
Days Receivable	27.67 Days	115.65 Days	108.17 Days
Days Payable	84.69 Days	154.91 Days	93.08 Days
5yr Average Interest Coverage Ratio	2.52	1.5	2385.83
5yr Avg ROCE	15.15 %	19.2 %	19.65 %
5yr Avg Operating Profit Margin	9.09 %	9.12 %	23.57 %
5 yr average Debt to Equity	0.55	1.95	0.0
5yr CAGR Net Profit	n/a	8.78 %	-6.96 %
5yr Average Return on Assets	3.55 %	1.88 %	12.43 %
Shareholdings
Promoter Holding	50.3 %	50.86 %	61.97 %
Share Pledged by Promoters	13.23 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.12 %	-1.14 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Mangalam Drugs&Org.	Bal Pharma	Tyche Inds
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Formulations 0 API 0 Manufacture of bulk drugs intermediates 0	Product Wise Break-Up Formulations 52.96 Manufacture of bulk drugs intermediates 0 Pharmaceutical 0 Active Pharmaceutical Ingredient (API) 43.44 Others 3.6	Product Wise Break-Up Formulations 0 Bulk Chemicals 100.0 Pharmaceutical 0 API 0
Location Wise Break-Up	Location Wise Break-Up Domestic 62.61 International 37.39 Rest of the World 0 India 0	Location Wise Break-Up Rest of the World 64.15 India 35.85 Domestic 0 International 0	Location Wise Break-Up Rest of the World 0 India 0 Domestic 32.67 International 47.91 Others 19.42
Raw Material Break-Up	Raw Material Break-Up Artimesinin 61.91 Lumefantrine-3 26.55 Ethyl Acetate 2.91 EMME 2.42 PMPA 0 Others 6.21	-	-